My Recent Searches
- No Recent Search.
My Tests Viewed
- No Test Viewed.
Showing search results for "thyroid cancer" 31-40 of 247
- NRAS Mutation Analysis
N-RAS mutations have been described in 12% of leukemias, 18% of skin cancers, 18% of small intestine cancers, 3% of colon cancers, and 7% of thyroid cancer.... More
- Metanephrines, Fractionated, LC/MS/MS, 24-Hour Urine
Test is useful in the evaluation of pheochromocytoma.... More
- Metanephrines, Fractionated, Free, LC/MS/MS, Plasma
Normetanephrine (NM) and metanephrine (MN) are the extra-neuronal catechol-o-methyl transferase (COMT) metabolites of the catecholamines norepinephrine and epinephrine, respectively. Measurement of plasma metanephrines …... More
- GIvantage Hereditary Colorectal Cancer Panel
This targeted panel includes 13 cancer genes related to colon, gastric, and pancreatic cancers and polyposis, among other cancer types. It consists mostly of high-penetrant genes for which NCCN has provided medical …... More
- Calcium, Ionized
The ionized calcium is determined by an ion selective electrode methodology. The result that is generated is pH adjusted. The result is empirically based on a measured pH and ionized calcium concentration normalized to …... More
- MYvantage Hereditary Comprehensive Cancer Panel
This panel provides comprehensive analysis of 34 hereditary cancer predisposition genes related to breast, ovarian, colon, skin and other cancer types to guide management. It is intended for use in both male and female …... More
- Colorectal Cancer Mutation Panel (KRAS, PIK3CA, BRAF, NRAS)
This panel detecting tumor-associated somatic mutations in 4 different oncogenes can predict response to EGFR-targeted immunotherapy in patients with metastatic colorectal cancer. Tumors with mutations in KRAS, NRAS, …... More
- Bladder Cancer, FISH
UroVysion FISH, detects aneuploidy of chromosomes 3,7,17 and loss of 9p21 locus. Useful for monitoring bladder cancer and in the initial diagnosis of bladder cancer in patients with hematuria.... More
- Lung Cancer (NSCLC), ALK 2p23 Rearrangement, FISH
Non-small cell lung cancer is the leading cause of cancer death worldwide. Tyrosine kinase inhibitors have been demonstrated to reduce lung cancer cell proliferation. The therapeutic efficacy of inhibiting ALK in tumors…... More
- Lung Cancer Mutation Panel (EGFR, KRAS, ALK)
This panel is comprised of mutational analysis of the EGFR and KRAS genes and assessment for ALK locus rearrangement using an FDA-cleared FISH assay. These are the most common tumor-associated genetic changes that have …... More
Didn't find the test that you were looking for?
Search for a test at a regional laboratory below.
Enter test name, test code, CPT or keyword
* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.